Cent Eur J Public Health 2007, 15(2):79-83 | DOI: 10.21101/cejph.a3417

Smoking Attributable Hospital Treatment, Treatment Costs and Smoking Attributable Mortality in the Czech Republic in 2002

Hana Sovinová, Ladislav Csémy, Bohumír Procházka, Stanislava Kottnauerová
National Institute of Public Health, Prague, Czech Republic

Objectives: The main objective of this work is to quantify the number of hospitalizations caused by smoking, estimate the costs of hospital treatment and to estimate contribution of smoking to mortality in the Czech Republic (CR) in 2002.

Methods: The estimate of the proportion by which smoking contributed to hospitalizations and to mortality in the CR was computed using the method of smoking-attributable fractions (SAF). The SAF was computed from relative risks established in the American study Cancer Prevention Study II and from estimates of the prevalence of smoking in the CR from a nationwide study conducted in 2002.

Results: In 2002, based on data provided by the General Health Insurance Company, there were 145,336 hospitalizations, and the total cost of hospital treatment was estimated as 4.727,612 (in thousands) CZK. The total number of deaths caused by smoking was 20,550 (95% CI: 18,851-22,262), 14,525 in men and 6,025 in women. Deaths caused by smoking represented 19% of the total nationwide mortality for 2002. Earlier estimates were published by Peto and Lopez for 1995 (22,300 deaths caused by smoking) and 2000 (17,746 deaths). The estimate arrived by authors using the SAF method for 2002 corresponds quite well with that by Peto and Lopez for 2000.

Conclusions: The high morbidity and mortality rate related to smoking is directly connected to high prevalence of smoking in the Czech Republic. An effective tobacco control policy, including restrictive measures on availability of tobacco products combined with preventive programmes and smoking cessation programmes, could contribute to the reduction of smoking and save lives and treatment costs caused by smoking.

Klíčová slova: hospitalizations, smoking, mortality, costs of treatment, Czech Republic

Vloženo: 9. leden 2007; Revidováno: 29. leden 2007; Přijato: 29. leden 2007; Zveřejněno: 1. červen 2007  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sovinová H, Csémy L, Procházka B, Kottnauerová S. Smoking Attributable Hospital Treatment, Treatment Costs and Smoking Attributable Mortality in the Czech Republic in 2002. Cent Eur J Public Health. 2007;15(2):79-83. doi: 10.21101/cejph.a3417. PubMed PMID: 17645223.
Sdílet...
Stáhnout citaci
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Zobrazit celý článek

    Reference

    1. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr. Mortality from smoking in developed countries 1950-2000. 2nd ed. Oxford: Oxford University Press; 2003.
    2. The world health report 2002. Reducing risks, promoting healthy life. Geneva: WHO; 2002.
    3. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet. 1992 May 23;339(8804):1268-78. Přejít k původnímu zdroji...
    4. Velkova A, Wolleswinkel-van den Bosch JH, Mackenbach JP. The East-West life expectancy gap: differences in mortality from conditions amenable to medical intervention. Int J Epidemiol. 1997 Feb;26(1):7584. Přejít k původnímu zdroji...
    5. Ezzati M, LopezAD. Estimates of global mortality attributable to smoking in 2000. Lancet. 2003 Sep 13;362(9387):847-52. Přejít k původnímu zdroji... Přejít na PubMed...
    6. Kříž J, editor. Population health: how are we off with our health? Prague: The National Institute of Public Health; 2004.
    7. Smoking-attributable mortality and years of potential life lost - United States, 1984. MMWR Morb Mortal Wkly Rep. 1997 May 23;46(20):44451.
    8. Centers for Disease Control and Prevention. 2002. Smoking-attributable mortality, morbidity, and economic costs (SAMMEC): adult SAMMEC and maternal and child health (MCH) SAMMEC software [homepage on the Internet]. Atlanta(CA): CDC. [cited 2007 Jan 9]. Available from: http://www.cdc.gov/tobacco/sammec.htm.
    9. Banegas JR, Diez Ganan L, Gonzalez Enriquez J, Villar Alvarez F, Rodriguez-Artalejo F. Recent decrease in smoking-attributable mortality in Spain. Med Clin. 2005 May 28; 124(20):769-71. (In Spanish.) Přejít k původnímu zdroji... Přejít na PubMed...
    10. Gorini G, Chellini E, QuerciA, Seniori CostantiniA. Impact of smoking in Italy in 1998: deaths and years of potential life lost. Epidemiol Prev. 2003 Sep-Oct;27(5):285-90. (In Italian.)
    11. Welte R, König HH, Leidl R. The costs of health damage and productivity losses attributable to cigarette smoking in Germany. Eur J Public Health. 2000 Mar;10(1):31-8. Přejít k původnímu zdroji...
    12. Bloomfield K, et al. Gender, culture and alcohol problems: a multi-national study [project final report]. Berlin: Institut for Medical Informatics, Biometrics and Epidemiology, Charité Universitätsmedizin Berlin; 2005.
    13. Thun MJ, Day-Lally C, Myers DG, Calle EE, Flanders DW, Zhu BP, et al. Trends in tobacco smoking and mortality from cigarette use in Cancer Prevention Studies I (1959 through 1965) and II (1982 through 1988). In: Smoking and tobacco control monograph 8: changes in cigarette-related disease risks and their implications for prevention and control. Bethesda: Cancer Institut; 1997. p. 305-82.
    14. Migration of the population in the Czech Republic in over the year 2002. Demographics 2003 [database on the Internet]. Prague: Czech Statistical office. [cited 2007 Jan 9]. Available from: http://www.czso.cz/csu/2003edicniplan.nsf/publ/4019-03-za_rok_2002.
    15. Ezzati M, Henley SJ, Lopez AD, Thun MJ. Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int J Cancer. 2005 Oct 10;116(6):963-71. Přejít k původnímu zdroji... Přejít na PubMed...
    16. Karimian-Teherani D, Vutuc C, Janout V. Mortality trends of lung cancer in Austria and the Czech Republic. Neoplasma. 2001;48(4):257-61. Přejít na PubMed...
    17. Kollarová H, Janout V, Čížek L. Epidemiology of lung cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2002 Dec;146(2):10314. Přejít k původnímu zdroji...
    18. Sharp L, Brewster D. The epidemiology of lung cancer in Scotland: a review of trends in incidence, survival and mortality and prospects for prevention. Health Bull. 1999 Sep;57(5):318-31.
    19. KubíkAK, Zatloukal P,Tomášek L, Petruželka L. Lung cancer risk among Czech women: a case-control study. Prev Med. 2002 Apr;34(4):43644. Přejít k původnímu zdroji...
    20. Cífková R, Škodová Z. Longitudinal trends in major cardiovascular disease risk factors in the Czech population. Cas Lek Cesk. 2004;143(4):21926. (In Czech.)
    21. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004 Mar 9;109(9):1101-7. Přejít k původnímu zdroji... Přejít na PubMed...
    22. Banegas JR, Rodriguez-Artalejo F, Graciani A, Villar F, Herruzo R. Mortality attributable to cardiovascular risk factors in Spain. Eur J Clin Nutr. 2003 Sep;57 Suppl 1:S18-S21. Přejít k původnímu zdroji... Přejít na PubMed...
    23. Sovinová H, Csémy L. The changing smoking and health scene in the Czech Republic. Nutrition. 2000 Nov-Dec;16(11-12):1112-3. Přejít k původnímu zdroji...
    24. Sovinová H, Csémy L, editors. Cigarette smoking and alcohol consumption in the Czech Republic. Prague: The National Institute of Public Health; 2003.

    Zpět na obsah